Poland - Pharmaceutical products

Description

The subject of the order is: supply of drugs in the drug program for the treatment of cystic fibrosis:Package No. 11) Ivacaftorum 75 mg + Tezacaftorum 50 mg + Elexacaftorum 100 mg x 56 tablets (Ka-ftrio) op. 3902) Ivacaftorum 150 mg x 28 tablets (Kalydeco) op. 390Package No. 21) Tezacaftorum 50 mg + Ivacaftorum 75 mg x 28 tablets (Symkevi) op. 602) Ivacaftorum 75 mg x 28 tablets (Kalydeco) op. 60Package no. 31) Tezacaftorum 100 mg + Ivacaftorum 150 mg x 28 tablets (Symkevi) op. 1202) Ivacaftorum 150 mg x 28 tablets (Kalydeco) op. 120Package no. 41) Ivacaftorum + Lumacaftorum (Orkambi) granules 188 mg + 150 mg x 56 sachets op. 40The purchase is made under Drug Program B.112 reimbursed by the National Health Fund entitled "Treatment of Cystic Fibrosis".The order must be carried out in accordance with the requirements specified in the SWZZ and the Draft Contractual Provisions.
Package No. 11) Ivacaftorum 75 mg + Tezacaftorum 50 mg + Elexacaftorum 100 mg x 56 tablets (Ka-ftrio) op. 3902) Ivacaftorum 150 mg x 28 tablets (Kalydeco) op. 390 Package No. 21) Tezacaftorum 50 mg + Ivacaftorum 75 mg x 28 tablets (Symkevi) op. 602) Ivacaftorum 75 mg x 28 tablets (Kalydeco) op. 60 Package No. 31) Tezacaftorum 100 mg + Ivacaftorum 150 mg x 28 tablets (Symkevi) op. 1202) Ivacaftorum 150 mg x 28 tablets (Kalydeco) op. 120 Package No. 41) Ivacaftorum + Lumacaftorum (Orkambi) granules 188 mg + 150 mg x 56 sachets op. 40

Opportunity closing date

02 January 2023

Value of contract

to be confirmed